Kirchheimer J C, Nong Y H, Remold H G
Department of Rheumatology and Immunology, Brigham and Women's Hospital, Boston, MA 02115.
J Immunol. 1988 Dec 15;141(12):4229-34.
The ability of macrophages to reach inflammatory loci is crucial in the function of cellular immunity. Invasive properties of macrophages may be due to the proteinase urokinase which binds to cell surface receptors, and thereby confers on macrophages the capacity for localized proteolysis of the interstitium. Here, we investigated the role of the macrophage-activating factors IFN-gamma, TNF-alpha, and granulocyte-macrophage-CSF and of urokinase on the expression of urokinase receptors by human cultured monocytes. IFN-gamma and TNF-alpha induced increased urokinase binding to human cultured monocytes in a time- and dose-dependent fashion. At optimal concentrations, IFN-gamma (200 U/ml) increased the number of receptors/cell from 14,000 to 64,000, TNF-alpha (50 U/ml) to 30,000, and combinations of IFN-gamma and TNF-alpha to 90,000. Granulocyte-macrophage-CSF had no effect. The enhanced urokinase binding is due to increased numbers of urokinase receptors and not an increased affinity of the receptor for urokinase. In the presence of urokinase during monocyte activation, IFN-gamma induced only 25,000 receptors/cell. However, urokinase does not inhibit increased receptor expression when the cells are activated with TNF-alpha. The effect of urokinase on induction of urokinase receptors by combinations of IFN-gamma and TNF-alpha varied with the dosage of TNF-alpha: A combination of IFN-gamma (200 U/ml) and TNF-alpha (15 U/ml) induced 38,000 receptors/cell in the presence and 90,000 receptors/cells in the absence of urokinase, whereas IFN-gamma (200 U/ml) and TNF-alpha (20 U/ml) induced 90,000 receptors/cell in the absence and presence of urokinase. These studies demonstrate that IFN-gamma, TNF-alpha, and urokinase collectively regulate the number of urokinase receptors on human monocytes. The induction of urokinase receptors may be responsible for increased invasiveness of the activated macrophage.
巨噬细胞抵达炎症位点的能力在细胞免疫功能中至关重要。巨噬细胞的侵袭特性可能归因于与细胞表面受体结合的蛋白酶尿激酶,从而赋予巨噬细胞对间质进行局部蛋白水解的能力。在此,我们研究了巨噬细胞激活因子γ干扰素、肿瘤坏死因子-α和粒细胞-巨噬细胞集落刺激因子以及尿激酶对人培养单核细胞尿激酶受体表达的作用。γ干扰素和肿瘤坏死因子-α以时间和剂量依赖的方式诱导尿激酶与人培养单核细胞的结合增加。在最佳浓度下,γ干扰素(200 U/ml)使每个细胞的受体数量从14,000增加到64,000,肿瘤坏死因子-α(50 U/ml)使其增加到30,000,γ干扰素和肿瘤坏死因子-α的组合使其增加到90,000。粒细胞-巨噬细胞集落刺激因子没有作用。尿激酶结合增强是由于尿激酶受体数量增加,而非受体对尿激酶的亲和力增加。在单核细胞激活过程中存在尿激酶时,γ干扰素仅诱导每个细胞25,000个受体。然而,当细胞用肿瘤坏死因子-α激活时,尿激酶并不抑制受体表达的增加。尿激酶对γ干扰素和肿瘤坏死因子-α组合诱导尿激酶受体的影响随肿瘤坏死因子-α的剂量而变化:γ干扰素(200 U/ml)和肿瘤坏死因子-α(15 U/ml)的组合在有尿激酶存在时诱导每个细胞38,000个受体,在无尿激酶时诱导90,000个受体/细胞,而γ干扰素(200 U/ml)和肿瘤坏死因子-α(20 U/ml)在无尿激酶和有尿激酶存在时均诱导90,000个受体/细胞。这些研究表明,γ干扰素、肿瘤坏死因子-α和尿激酶共同调节人单核细胞上尿激酶受体的数量。尿激酶受体的诱导可能是激活的巨噬细胞侵袭性增加的原因。